Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical

Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia

Patricia Bobo, Jonas Z. HinesComments to Author , Roma Chilengi, Andrew F. Auld, Simon G. Agolory, Andrew Silumesii, and John Nkengasong
Author affiliations: Ministry of Health, Lusaka, Zambia (P. Bobo, A. Silumesii); US Centers for Disease Control and Prevention, Lusaka (J.Z. Hines, S.G. Agolory); Republic of Zambia State House, Lusaka (R. Chilengi); The Global Fund, Geneva, Switzerland (A.F. Auld); Africa Center for Disease Control, Addis Ababa, Ethiopia (J. Nkengasong)

Main Article

Figure

Time series of COVID-19 vaccination in Zambia, April 2021 to February 2022. A) Before and after the December Campaign. B) Compared with 2 neighboring countries with similar pre-intervention vaccination coverage trajectories and similar vaccine availability. C) Compared with the average for all 55 Africa Union member states. Prais-Winsten and Cochrane-Orcutt regression, lag(1). Vertical dashed line indicates start of Joint HIV Awareness and COVID-19 Vaccination Drive, December 1, 2021.

Figure. Time series of COVID-19 vaccination in Zambia, April 2021 to February 2022. A) Before and after the December Campaign. B) Compared with 2 neighboring countries with similar pre-intervention vaccination coverage trajectories and similar vaccine availability. C) Compared with the average for all 55 Africa Union member states. Prais-Winsten and Cochrane-Orcutt regression, lag(1). Vertical dashed line indicates start of Joint HIV Awareness and COVID-19 Vaccination Drive, December 1, 2021.

Main Article

Page created: October 11, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external